These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 39084759)

  • 1. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.
    Said SM; Sethi S; Valeri AM; Leung N; Cornell LD; Fidler ME; Herrera Hernandez L; Vrana JA; Theis JD; Quint PS; Dogan A; Nasr SH
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1515-23. PubMed ID: 23704299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series.
    Murphy CL; Wang S; Kestler D; Larsen C; Benson D; Weiss DT; Solomon A
    Am J Kidney Dis; 2010 Dec; 56(6):1100-7. PubMed ID: 20951486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Immunoglobulin Amyloidosis-Mediated Kidney Disease: Emerging Understanding of Underdiagnosed Entities.
    Karam S; Kaushal A; Abu Amer N; Royal V; KItchlu A
    Adv Kidney Dis Health; 2024 Jul; 31(4):334-345. PubMed ID: 39084759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal amyloidosis: an update on diagnosis and pathogenesis.
    Gupta N; Kaur H; Wajid S
    Protoplasma; 2020 Sep; 257(5):1259-1276. PubMed ID: 32447467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LECT-2 amyloidosis: what do we know?
    Mann BK; Bhandohal JS; Cobos E; Chitturi C; Eppanapally S
    J Investig Med; 2022 Feb; 70(2):348-353. PubMed ID: 34848562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
    Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
    Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
    Picken MM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.